Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity

Journal of Neuroscience

Volumn 31, Issue 11, 2011, Pages 3990-3999

  Baltan, Selva ^a   Murphy, Sean P ^a   Danilov, Camelia A ^a   Bachleda, Amelia ^a   Morrison, Richard S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENTINOSTAT; GLUCOSE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; OXYGEN; VORINOSTAT;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN FUNCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; CYTOARCHITECTURE; ENZYME LOCALIZATION; EXCITOTOXICITY; GENETIC TRANSCRIPTION; GLIA CELL; MALE; MITOCHONDRION; MOUSE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; UPREGULATION; WHITE MATTER;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; AXONS; BRAIN ISCHEMIA; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; HISTONE DEACETYLASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE FIBERS, MYELINATED;

EID: 79952759556     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5379-10.2011     Document Type: Article

References (50)

1. Allritz C, Bette S, Figiel M, Engele J (2009) Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. Neurochem Int 55:22-27.
2. Balasubramaniyan V, Boddeke E, Bakels R, Küst B, Kooistra S, Veneman A, Copray S (2006) Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 143:939-951. (Pubitemid 44827521)
3. Baltan S (2009) Ischemic injury to white matter: an age-dependent process. Neuroscientist 15:126-133.
4. Baltan S, Besancon EF, Mbow B, Ye Z, Hamner MA, Ransom BR (2008) White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 28:1479-1489. (Pubitemid 351231538)
5. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gräber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25:3900-3911. (Pubitemid 44300275)
6. Carey N, La Thangue NB (2006) Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol 6:369-375. (Pubitemid 44040838)
7. Chang DT, Reynolds IJ (2006) Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 141:727-736. (Pubitemid 44066636)
8. Chiechio S, Zammataro M, Morales ME, Busceti CL, Drago F, Gereau RW 4th, Copani A, Nicoletti F (2009) Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol 75:1014-1020.
9. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32:591-601.
10. Clayton AL, Hazzalin CA, Mahadevan LC (2006) Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23:289-296. (Pubitemid 44128853)
11. Cummins KL, Perkel DH, Dorfman LJ (1979) Nerve fiber conduction-velocity distributions. I. Estimation based on the single-fiber and compound action potentials. Electroencephalogr Clin Neurophysiol 46:634-646.
12. Dabir DV, Robinson MB, Swanson E, Zhang B, Trojanowski JQ, Lee VM, Forman MS (2006) Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26:644-654. (Pubitemid 43237129)
13. Fern R, Ransom BR, Waxman SG (1995) Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J Neurophysiol 74:369-377.
14. Foster RE, Connors BW, Waxman SG (1982) Rat optic nerve: electrophysiological, pharmacological and anatomical studies during development. Dev Brain Res 3:371-386. (Pubitemid 12114865)
15. Gibson CL, Murphy SP (2010) Benefits of histone deacetylase inhibitors for acute brain injury; a systematic review of animal studies. J Neurochem 115:806-813.
16. Goldberg MP, Choi DW (1993) Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 13:3510-3524. (Pubitemid 23241187)
17. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32-42.
18. Hess-Stumpp H, Bracker TU, Henderson D, Politz O (2007) MS-275, a potent orally available inhibitor of histone deacetylases - the development of an anticancer agent. Int J Biochem Cell Biol 39:1388-1405. (Pubitemid 47031032)
19. Johannessen CU (2000) Mechanisms of action of valproate: a commentatory. Neurochem Int 37:103-110.
20. Kawahara K, Kosugi T, Tanaka M, Nakajima T, Yamada T (2005) Reversed operation of glutamate transporter GLT-1 is crucial to the development of preconditioning-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures. Glia 49:349-359. (Pubitemid 40222913)
21. Khan HA (2003) Bioluminometric assay of ATP in mouse brain: determinant factors for enhanced test sensitivity. J Biosci 28:379-382.
22. Kosugi T, Kawahara K, Yamada T, Nakajima T, Tanaka M (2005) Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures. Neurochem Res 30:1109-1116. (Pubitemid 41642153)
23. waf1/cip1 in cell cycle-independent neuroprotection. J Neurosci 28:163-176.
24. Langley B, Brochier C, Rivieccio MA (2009) Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke 40:2899-2905.
25. Li S, Mallory M, Alford M, Tanaka S, Masliah E (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56:901-911. (Pubitemid 27329111)
26. Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20:589-602. (Pubitemid 28153087)
27. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622.
28. Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38-51. (Pubitemid 43054973)
29. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW (2007) Imaging axonal transport of mitochondria in vivo. Nat Methods 4:559-561. (Pubitemid 47214773)
30. Morland C, Boldingh KA, Iversen EG, Hassel B (2004) Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. J Cereb Blood Flow Metab 24:1226-1234. (Pubitemid 39482484)
31. Nicholls DG, Johnson-Cadwell L, Vesce S, Jekabsons M, Yadava N (2007) Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res 85:3206-3212. (Pubitemid 350058509)
32. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 13:1441-1453. (Pubitemid 23095389)
33. Rintoul GL, Filiano AJ, Brocard JB, Kress GJ, Reynolds IJ (2003) Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 23:7881-7888. (Pubitemid 37052356)
34. Romera C, Hurtado O, Botella SH, Lizasoain I, Cárdenas A, Fernández-Tomé P, Leza JC, Lorenzo P, Moro MA (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ ADAM17-tumor necrosis factor-α pathway. J Neurosci 24:1350-1357.
35. Rothstein JD, Kuncl RW (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65:643-651.
36. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686. (Pubitemid 26103145)
37. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73-77. (Pubitemid 40101145)
38. Siebzehnrubl FA, Buslei R, Eyupoglu IY, Seufert S, Hahnen E, Blumcke I (2007) Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp Brain Res 176:672-678. (Pubitemid 46175198)
39. Stys PK, Ransom BR, Waxman SG, Davis PK (1990) Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A 87:4212-4216.
40. 2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 30:375-380.
41. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702. (Pubitemid 27421977)
42. Tekkök SB, Goldberg MP (2001) AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21:4237-4248.
43. Tekkök SB, Ye Z, Ransom BR (2007) Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 27:1540-1552. (Pubitemid 47301441)
44. Thomas EA (2009) Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors. Mol Neurobiol 40:33-45.
45. Torp R, Lekieffre D, Levy LM, Haug FM, Danbolt NC, Meldrum BS, Ottersen OP (1995) Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp Brain Res 103:51-58.
46. Underhill SM, Goldberg MP (2007) Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors. Neurobiol Dis 25:284-290. (Pubitemid 46124009)
47. Uo T, Veenstra TD, Morrison RS (2009) HDAC inhibitors prevent p53-dependent and-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J Neurosci 29:2824-2832.
48. Wolf JA, Stys PK, Lusardi T, Meaney D, Smith DH (2001) Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci 21:1923-1930. (Pubitemid 32221376)
49. WuJY, Niu FN, Huang R, Xu Y (2008) Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. Neuroreport 19:1209-1212.
50. Zhang M, Li WB, Geng JX, Li QJ, Sun XC, Xian XH, Qi J, Li SQ (2007) The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J Cereb Blood Flow Metab 27:1352-1368. (Pubitemid 46985352)